Welcome to LookChem.com Sign In|Join Free
  • or
2-(3,4,5-trimethoxystyryl)-quinazoline-4(3H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

793691-64-2

Post Buying Request

793691-64-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

793691-64-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 793691-64-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 7,9,3,6,9 and 1 respectively; the second part has 2 digits, 6 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 793691-64:
(8*7)+(7*9)+(6*3)+(5*6)+(4*9)+(3*1)+(2*6)+(1*4)=222
222 % 10 = 2
So 793691-64-2 is a valid CAS Registry Number.

793691-64-2Relevant academic research and scientific papers

Synthesis and evaluation of novel 4-substituted styryl quinazolines as potential antimicrobial agents

Modh, Rahul P.,Patel, Amit C.,Mahajan, Dharmesh H.,Pannecouque, Christophe,De Clercq, Erik,Chikhalia, Kishor H.

, p. 964 - 972 (2013/02/22)

In an attempt to afford possible antibacterial and anti-human immunodeficiency virus (HIV) agents, a series of 22 novel styryl quinazoline-based heterocyclic entities were designed and synthesized. Various substituted aryl urea and thiourea cores were incorporated at position 4 of quinazoline, followed by styrylation of position 2, aiming at an augmented biological potential. The synthesized compounds were well characterized through IR, 1H NMR, 13C NMR and elemental analyses. All compounds were screened for their in vitro anti-HIV activity against the HIV-1 (IIIB) and HIV-2 (ROD) strains. The antibacterial activity was also evaluated against various pathogenic Gram-positive and Gram-negative bacterial strains. A series of 22 novel styryl quinazoline-based heterocyclic entities were designed and synthesized to afford possible antibacterial and anti-human immunodeficiency virus (HIV) agents. All of the prepared compounds were screened for their in vitro anti-HIV activity against the HIV-1 (IIIB) and HIV-2 (ROD) strains. The antibacterial activity was also evaluated against various pathogenic Gram-positive and Gram-negative bacterial strains. Copyright

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 793691-64-2